Skip to main content

Table 1 Comparison of mean global and segmental native T1 relaxation time and mean global and segmental ECV values and other parameters between DMD-FC and the CG

From: Myocardial native T1 mapping and extracellular volume quantification in asymptomatic female carriers of Duchenne muscular dystrophy gene mutations

Parameter

DMD-FC (n = 38)

CG (n = 22)

P-value

Age [years]

39 ± 8.8

39.9 ± 12.6

0.76

BMI [kg/m2]

23.8 ± 3.4

23.17 ± 3.9

0.64

LVEF [%]

65.6 ± 5.5

68.4 ± 6.57

0.33

Global native Trelaxation time [ms]

1005.1 ± 26.3

1003.5 ± 25.0

0.81

Native Trelaxation time [ms]: anterior segment

997.3 ± 33.7

1006.7 ± 35.9

0.31

Native Trelaxation time [ms]: anteroseptal segment

1001.5 ± 35.2

994.9 ± 26.9

0.45

Native Trelaxation time [ms]: inferoseptal segment

1013.8 ± 26.0

1004.5 ± 30.8

0.22

Native Trelaxation time [ms]: inferior segment

1008.7 ± 40.1

1003.5 ± 31.9

0.60

Native Trelaxation time [ms]: inferolateral segment

1012.5 ± 32.4

1012.4 ± 36.7

0.99

Native Trelaxation time [ms]: anterolateral segment

992.8 ± 32.0

1004.7 ± 37.0

0.19

Global ECV value [%]

27.93 ± 2.02

27.10 ± 2.89

0.20

ECV value: anterior segment

27.86 ± 2.35

26.90 ± 2.66

0.16

ECV value: anteroseptal segment

27.72 ± 2.10

27.62 ± 3.17

0.88

ECV value: inferoseptal segment

28.41 ± 2.21

27.73 ± 3.25

0.34

ECV value: inferior segment

28.26 ± 2.62

26.79 ± 3.65

0.075

ECV value: inferolateral segment

27.83 ± 2.94

26.30 ± 3.34

0.070

ECV value: anterolateral segment

27.63 ± 2.30

27.02 ± 3.12

0.39

  1. Parameters are shown as mean ± standard deviation
  2. BMI = body mass index; ECV = extracellular volume; DMD- FC = Female carriers of Duchenne muscular dystrophy gene mutations; CG = Control group; LVEF = left ventricle ejection fraction